Abstract:Cinnamomum migao H. W. Li is an evergreen woody plant that is only distributed in southwest China. The volatile oils from the fruits of C. migao have long been used as a special authentic medicinal herb by local ethnic minorities. Due to its low seed germination rate, destructive lumbering and low rates of artificial planting, C. migao is facing the danger of extinction. Therefore, it is urgent to exploit and protect this species using molecular biological technology, especially to target the genes involved in the biosynthesis of terpenoids in the volatile oil. However, the genomic data for this plant are not available. In this study, the transcriptome sequencing of C. migao was performed to obtain the key genes involved in terpenoid biosynthesis via a combination of full-length transcriptome and next-generation sequencing (NGS). More than 39.9 Gb of raw data was obtained and 515,929 circular consensus sequences (CCSs) were extracted. After clustering similar 472,858 full-length non-chimeric (FLNC) reads and correction with NGS data, 139,871 consensus isoforms were obtained. Meanwhile, 73,575 non-redundant transcripts were generated by removing redundant transcripts. Then, 70,427 isoforms were successfully annotated using public databases. Moreover, differentially expressed transcripts (DETs) in four different developmental stages of the C. migao fruit were analyzed and 5764 transcripts showed period-specific expression. Finally, 15 transcripts, 6 transcripts, and only 1 transcript were identified as being involved in the biosynthesis of sesquiterpenoids, diterpenoids, and monoterpenoids, respectively. This study provides a basis for future research in the gene mining, genetic breeding, and metabolic engineering of C. migao.

Cinnamigones A–C, three highly oxidized guaiane-type sesquiterpenes with neuroprotective activity from Cinnamomum migao

Vicinal Diol Sesquiterpenes from Cinnamomum migao with Neuroprotective Effects in PC12 Cells

An extensive pharmacological evaluation of novel anti-nociceptive and IL-6 targeted anti-inflammatory guaiane-type sesquiterpenoids from Cinnamomum migao H. W. Li through in-depth in- vitro , ADMET, and molecular docking studies

Undescribed secondary metabolites derived from Cinnamomum migao H. W. Li, showcasing anti-inflammatory, antioxidant, and in silico properties

Guignardones A-C: Three meroterpenes from Guignardia mangiferae

Bioactive Phenolics and Terpenoids from Manglietia Insignis.

Guignardones A–C: Three Meroterpenes from <i>Guignardia mangiferae</i>

Dimeric guaianolides and sesquiterpenoids from Artemisia anomala.

Guaianolide sesquiterpene lactones from Cichorium glandulosum and their anti-neuroinflammation activities

Cytotoxic metabolites from the mangrove endophytic fungus Aspergillus sp. GXNU QG1a

Glaucatotones A−I: Guaiane-type sesquiterpenoids from the roots of Lindera glauca with anti-inflammatory activity

Guaiane‐type sesquiterpenoid dimers from Artemisia zhongdianensis and antihepatoma carcinoma activity via the p38MAPK pathway

Epigenetic Manipulation to Trigger Production of Guaiane-Type Sesquiterpenes from a Marine-Derived Spiromastix Sp. Fungus with Antineuroinflammatory Effects.

New Guaiane-Type Sesquiterpenoids Biscogniauxiaols A-G with Anti-Fungal and Anti-Inflammatory Activities from the Endophytic Fungus Biscogniauxia Petrensis

Diverse guaiane-type sesquiterpenoids from the root of Daphne genkwa based on molecular networking

Two New Sesquiterpenoids and a New Shikimic Acid Metabolite from Mangrove Sediment-Derived Fungus Roussoella sp. SCSIO 41427

Guaiane-type sesquiterpenoids from the roots of Stellera chamaejasme L. and their neuroprotective activities

Full-Length Transcriptome Sequencing and Identification of Genes Related to Terpenoid Biosynthesis in Cinnamomum migao H. W. Li

[Two new sesquiterpenes in Qi-nan Aquilariae Lignum Resinatum].

Aromatic monoterpenoid glycosides from rattan stems of Schisandra chinensis and their neuroprotective activities

New anti-inflammatory guaianes from the Atlantic hydrotherm-derived fungus Graphostroma sp. MCCC 3A00421